Real-World Impact
How QurieGen's High-Resolution Cellular Mapping, Derisk R&D, Save Time, and Unlock Novel Biology
QurieGen transforms drug development from an extreme risk problem into an engineering solution. Explore how leading pharmaceutical companies use our platform to gain high-resolution, quantitative insights, accelerate their pipelines up to four times faster, and avoid costly late-stage failures.
4X
Biomarker Discovery
Faster R&D Execution
Identifying novel biomarkers for patient stratification.
10×
Mechanism of Action
More mechanistic insights
Elucidating complex drug interactions at single-cell resolution.
Virtual Screening
Saving costs and time
Simulating drug efficacy before wet-lab testing.
Our Workflow
We partner with you end-to-end - from experimental design through biological insight and we take on projects that don’t come with a manual.
01
Project design
- •We start by working side-by-side with you to shape studies around your real scientific questions.
- •Our proprietary single-cell platform is configured specifically for each project—no templates, no black boxes.
- •Need scale? We design large, bespoke antibody panels (350+ antibodies) in-house to match your biology, not the other way around.
01
02
03
01
02
Platform in action
- •Experiments live inside our integrated platform and are executed using rigorously validated workflows.
- •We apply advanced single-cell multi-omic technologies in direct alignment with the study we designed together.
- •A dedicated PhD-level scientific team stays with your project end-to-end, keeping the science tight and the goals front and center.
03
From data to insight
- •Your multimodal data flow through a scalable, high-performance analytics pipeline built for biological discovery.
- •Machine-learning–driven analyses turn complexity into clarity and signals into insight.
- •We don’t stop at results: we work with you to interpret the findings and co-design the next set of experiments and follow-up projects.
Deep Dive Case Studies
Explore how our partners are using QuRIE-seq to solve critical R&D challenges.
